Atlas Trials

SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer

Clinical trial NCT02704156 · COMPLETED

Trial details

NCT number
NCT02704156
Sponsor
Changhai Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2016-10-01
Primary completion
2020-12-01
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.